Skip to main content

ScienceDex / Researcher record

Cleveland, John L.

From the FY2011 NIH awards this investigator leads as contact PI. The department is the award's.

FY2011 NIH rank #6,016
  • Sustained Excellence
  • R01 Holder
  • Long-Funded

NIH Funding · FY2011

$1.1M
Full award amounts, FY2011
3
Records listing this PI
#6,016
By linked amount among FY2011 PIs
2006
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2006$958,4225#5,559
2007$972,2963#6,799
2008$345,8241#20,008
2009$1,136,2493#6,852
2010$1,082,1753#7,516
2011$1,133,3443#6,016
2012$2,815,1126#1,621
2013$2,343,2646#2,055
2014$1,976,6316#2,957
2015$980,3362#7,125
2016$948,2552#7,406
2019$3,383,3475#1,277
2020$3,178,0162#390
2021$4,128,5388#993
2022$5,393,7169#643
2023$5,555,0006#611

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20065 records
  2. FY20073 records
  3. FY20081 record
  4. FY20093 records
  5. FY20103 records
  6. FY2011 · selected3 records
  7. FY20126 records
  8. FY20136 records
  9. FY20146 records
  10. FY20152 records
  11. FY20162 records
  12. FY20195 records
  13. FY20202 records
  14. FY20218 records
  15. FY20229 records
  16. FY20236 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Cleveland, John L.. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2011 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2011 award records by amount

NIH award records listing Cleveland, John L. as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA100603-09R01Contact PI
    Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer
    $417.3K
    award amount
  • 4R01CA076379-13R01Contact PI
    Interplay of Myc, Tumor Supressors and Regulators of Differentiation in Lymphoma
    $363.2K
    award amount
  • 5R01GM085079-02R01Contact PI
    The Anatomy and Regulation of Mouse Recombination Hotspots.
    $352.8K
    award amount

Award organizations

Organizations that administered FY2011 awards listing Cleveland, John L. as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Scripps Florida
  2. 2006
    $500K Cumulative Funding
  3. 2006
    Entered Top 50% Nationally
    Ranked #5559
  4. 2007
    $1M Cumulative Funding
  5. 2007
    Multi-Institutional Research
    Awards at 2 institutions
  6. 2008
    $2M Cumulative Funding
  7. 2011
    $5M Cumulative Funding
  8. 2011
    R01 Grant Holder
  9. 2012
    Entered Top 25% Nationally
    Ranked #1621
  10. 2012
    Entered Top 10% Nationally
    Ranked #1621
  11. 2013
    $10M Cumulative Funding
  12. 2020
    Entered Top 5% Nationally
    Ranked #390
  13. 2021
    $25M Cumulative Funding